TOTAL-BODY CLEARANCE OF INFUSIONAL 5-FLUOROURACIL (5FU)

被引:0
|
作者
FLOYD, R
GRIFFITHS, J
HORNBECK, C
FRANKEL, S
SHARP, T
BYFIELD, J
机构
[1] VET ADM,MED CTR,SAN DIEGO,CA 92161
[2] UNIV SO CALIF,LOS ANGELES,CA 90033
[3] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92103
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:395 / 395
页数:1
相关论文
共 50 条
  • [21] Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 235 - 237
  • [22] Effect of vehicles on topical delivery of 5-fluorouracil (5FU) by 1-acyl-5FU prodrugs
    Patrick, AI
    Beall, HD
    Gilroy, P
    Sloan, KB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) : 39 - 48
  • [23] EXAMINATION OF DIRECT CARDIAC EFFECTS OF 5-FLUOROURACIL (5FU) IN THE ISOLATED DOG HEART
    HERMAN, E
    WARAVDEKAR, N
    YOUNG, R
    KROP, S
    PHARMACOLOGIST, 1979, 21 (03): : 162 - 162
  • [24] PHARMACOKINETICS AND PHARMACODYNAMICS OF LOCOREGIONAL 5-FLUOROURACIL (5FU) IN ADVANCED COLORECTAL LIVER METASTASES
    GOLDBERG, JA
    KERR, DJ
    WILLMOTT, N
    MCKILLOP, JH
    MCARDLE, CS
    BRITISH JOURNAL OF CANCER, 1988, 57 (02) : 186 - 189
  • [25] 5-Fluorouracil (5FU) intratumoural pharmacokinetics: Rapid uptake in cells and in spheroids (SPH)
    Jove, M.
    Loadman, P.
    Wicks, J.
    Spencer, J.
    Race, A.
    Salazar, R.
    Twelves, C. J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] A COMMON CULPRIT AND AN IRISH DELAY: 5-FLUOROURACIL (5FU) INDUCED TRANSIENT MYOCARDITIS
    McKittrick, Myles
    McKittrick, Seoidin Elizabeth
    Gallen, Rory
    Fitzhenry, Niamh
    Millar, Kevin
    O'Hanlon, Rory
    Waterhouse, Deirdre
    Brennan, Alice
    Abbas, Syed F.
    Hennessy, Terence
    Arnous, Samer
    Ullah, Ihsan
    Muradagha, Hani
    Kiernan, Thomas
    Tuohy, Stephen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2642 - 2642
  • [27] The impact of sarcopenia on toxicity and pharmacokinetics of 5-fluorouracil (5FU) in colorectal cancer.
    Williams, Grant Richard
    Deal, Allison Mary
    Shachar, Shlomit S.
    Walko, Christine Marie
    Patel, Jai Narendra
    O'Neil, Bert H.
    McLeod, Howard L.
    Weinberg, Marc
    Choi, Seul Ki
    Muss, Hyman B.
    Sanoff, Hanna Kelly
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [28] PROTRACTED INFUSIONAL 5-FLUOROURACIL (5-FU) AS NEOADJUVANT AND RADIATION SENSITIZOR IN GASTROINTESTINAL CANCER
    LOKICH, J
    RICH, T
    CHAFFEY, J
    CANCER DRUG DELIVERY, 1986, 3 (01): : 67 - 67
  • [29] Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor
    Peters, GJ
    van Groeningen, CJ
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4267 - 4268
  • [30] INTERACTION OF 5-FLUOROURACIL AND TOTAL-BODY IRRADIATION IN MURINE HEMATOPOIETIC-TISSUE
    NIELSEN, OS
    VONDERMAASE, H
    OVERGAARD, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1542 - 1542